It has been a few weeks since we responded to some questions from the Biotech MailbagSince I have received quite a few recently on some small biotech stocks I have covered frequently on these pages, I thought it was past time to go back to the mailbag for a columnShould I worry about the huge shelf offering Dynavax Technologies Corprecently filed?...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.